Of the 93 patients in Group 2 with relevant available data in their medical records (n = 80/93), half (50%, n = 40/80; n = 13 had no data recorded) had at least one outpatient visit within the post-DOAC observation period related to AF or FXa-inhibiting DOACs, and of these, 40% (n = 16/40) had a single visit and 60% (n = 24/40) had 2 or more (Table 2). This evidence concerns the gene F10 and atrial fibrillation.